An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis

Condition:   Nasal Polyps
Interventions:   Drug: dupilumab SAR231893 (REGN668);   Other: placebo;   Drug: mometasone furoate nasal spray
Sponsors:   Sanofi;   Sanofi;   Regeneron Pharmaceuticals
Not yet recruiting – verified August 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.